Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing aspirin and butalbital and caffeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminophylline hydrate 350mg modified-release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminophylline hydrate 225mg modified-release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminophylline hydrate 100mg modified-release tablets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amrinone (substance) |
Is a |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ergotamine + caffeine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental phosphodiesterase inhibitor poisoning |
Causative agent (attribute) |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Intentional phosphodiesterase inhibitor poisoning |
Causative agent (attribute) |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Caffeine 65 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely caffeine 30 milligram and paracetamol 450 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine 25 mg and paracetamol 450 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine- and paracetamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Paracetamol+caffeine 500mg/65mg soluble tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing caffeine and ergotamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Roflumilast (substance) |
Is a |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phosphodiesterase 4 inhibitor |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline anhydrous |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline sodium glycinate |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline sodium acetate (substance) |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline monohydrate |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline calcium salicylate |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Choline theophyllinate (substance) |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine citrate (substance) |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine hydrate (substance) |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Milrinone lactate |
Is a |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine monohydrate (substance) |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaverine (substance) |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaveretum (substance) |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papaverine hydrochloride |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to phosphodiesterase inhibitor (finding) |
Causative agent (attribute) |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amrinone lactate |
Is a |
False |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Doxofylline |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Substance with phosphodiesterase 3 inhibitor mechanism of action (substance) |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine anhydrous |
Is a |
True |
Phosphodiesterase inhibitor |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|